Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Times Interest Earned (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Times Interest Earned data on record, last reported at -$5.47 in Q4 2025.

  • For Q4 2025, Times Interest Earned fell 12.68% year-over-year to -$5.47; the TTM value through Dec 2025 reached -$1.57, up 77.53%, while the annual FY2025 figure was -$1.57, 77.53% up from the prior year.
  • Times Interest Earned reached -$5.47 in Q4 2025 per VRCA's latest filing, down from $0.78 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $108.96 in Q4 2022 and bottomed at -$14.43 in Q3 2023.
  • Average Times Interest Earned over 5 years is $1.27, with a median of -$6.63 recorded in 2024.
  • The widest YoY moves for Times Interest Earned: up 1511.27% in 2022, down 11833.64% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at -$7.72 in 2021, then soared by 1511.27% to $108.96 in 2022, then tumbled by 109.21% to -$10.04 in 2023, then soared by 51.61% to -$4.86 in 2024, then dropped by 12.68% to -$5.47 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$5.47 in Q4 2025, $0.78 in Q3 2025, and $0.71 in Q2 2025.